Sensorion successfully raises €8.65 millions from institutional investors. pdfRead

Sensorion launches a share capital increase of newly issued ordinary shares. pdfRead

World Health Organization grants name ‘Seliforant’ to Sensorion’s SENS-111 treatment. pdfRead

Sensorion annonce le renouvellement de son label " entreprise innovante " accordé par Bpifrance. pdfLire

Mise à disposition du Rapport Financier annuel 2017. pdfLire

Next events